昼夜调节器REV-ERBα的功能逆转导致瘤基因基因重编程
Yatian Yang1, Xiong Zhang1, Demin Cai1
1Department of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, CA 95817.
概括
循环节律 (CR) 调节器REV-ERBα在癌症中切换功能,成为推动瘤生长的强有力的激活剂. 用SR8278和BRD4抑制剂准这种开关可以有效地抑制癌症的进展.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 时间生物学 时间生物学
背景情况:
- 昼夜节律 (CR) 的失调与癌症有关,但潜在的机制尚不清楚.
- REV-ERBα是一种关键的CR调节剂,与细胞平衡和疾病有关.
- 了解REV-ERBα在瘤发生中的作用对于开发新的癌症疗法至关重要.
研究的目的:
- 为了研究REV-ERBα在癌症中的功能性改变.
- 阐明REV-ERBα驱动瘤发生的分子机制.
- 评估针对REV-ERBα在癌症治疗中的治疗潜力.
主要方法:
- 在瘤样本中分析REV-ERBα基因组结合和功能模式.
- 研究REV-ERBα的蛋白质复合体关联 (NCoR/HDAC3与BRD4/p300).
- 在临床前癌症模型中药理上抑制REV-ERBα (SR8278) 和BRD4.
主要成果:
- REV-ERBα在癌症中经历了功能逆转,从抑制剂转变为强大的激活剂.
- 激活的REV-ERBα直接上调数千个基因,包括瘤信号通路 (MAPK,PI3K-Akt).
- 对REV-ERBα和BRD4的联合向协同抑制瘤生长和瘤致癌程序.
结论:
- REV-ERBα的功能开关是癌症发展的新范式,重编程基因表达向瘤产生.
- 针对REV-ERBα功能逆转是一种有前途的治疗策略,用于各种癌症.
- 涉及SR8278和BRD4抑制剂的联合治疗显示出显著的抗瘤疗效.
相关概念视频
Circadian Rhythms and Gene Regulation
4.0K
The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent...
4.0K
Somatic to iPS Cell Reprogramming
2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Negative Regulator Molecules
35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K


